186 related articles for article (PubMed ID: 30188977)
1. Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Casali PG; Abecassis N; Aro HT; Bauer S; Biagini R; Bielack S; Bonvalot S; Boukovinas I; Bovee JVMG; Brodowicz T; Broto JM; Buonadonna A; De Álava E; Dei Tos AP; Del Muro XG; Dileo P; Eriksson M; Fedenko A; Ferraresi V; Ferrari A; Ferrari S; Frezza AM; Gasperoni S; Gelderblom H; Gil T; Grignani G; Gronchi A; Haas RL; Hassan B; Hohenberger P; Issels R; Joensuu H; Jones RL; Judson I; Jutte P; Kaal S; Kasper B; Kopeckova K; Krákorová DA; Le Cesne A; Lugowska I; Merimsky O; Montemurro M; Pantaleo MA; Piana R; Picci P; Piperno-Neumann S; Pousa AL; Reichardt P; Robinson MH; Rutkowski P; Safwat AA; Schöffski P; Sleijfer S; Stacchiotti S; Sundby Hall K; Unk M; Van Coevorden F; van der Graaf WTA; Whelan J; Wardelmann E; Zaikova O; Blay JY;
Ann Oncol; 2018 Oct; 29(Suppl 4):iv267. PubMed ID: 30188977
[No Abstract] [Full Text] [Related]
2. Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Casali PG; Abecassis N; Aro HT; Bauer S; Biagini R; Bielack S; Bonvalot S; Boukovinas I; Bovee JVMG; Brodowicz T; Broto JM; Buonadonna A; De Álava E; Dei Tos AP; Del Muro XG; Dileo P; Eriksson M; Fedenko A; Ferraresi V; Ferrari A; Ferrari S; Frezza AM; Gasperoni S; Gelderblom H; Gil T; Grignani G; Gronchi A; Haas RL; Hassan B; Hohenberger P; Issels R; Joensuu H; Jones RL; Judson I; Jutte P; Kaal S; Kasper B; Kopeckova K; Krákorová DA; Le Cesne A; Lugowska I; Merimsky O; Montemurro M; Pantaleo MA; Piana R; Picci P; Piperno-Neumann S; Pousa AL; Reichardt P; Robinson MH; Rutkowski P; Safwat AA; Schöffski P; Sleijfer S; Stacchiotti S; Sundby Hall K; Unk M; Van Coevorden F; van der Graaf WTA; Whelan J; Wardelmann E; Zaikova O; Blay JY;
Ann Oncol; 2018 Oct; 29(Suppl 4):iv268-iv269. PubMed ID: 30285214
[No Abstract] [Full Text] [Related]
3. Corrigendum to "Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology volume 31 (2020) 1476-1490].
Fassnacht M; Assie G; Baudin E; Eisenhofer G; Fouchardiere C; Haak HR; de Krijger R; Porpiglia F; Terzolo M; Berruti A;
Ann Oncol; 2023 Jul; 34(7):631. PubMed ID: 36564283
[No Abstract] [Full Text] [Related]
4. Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
ESMO/European Sarcoma Network Working Group
Ann Oncol; 2014 Sep; 25 Suppl 3():iii21-6. PubMed ID: 25210085
[No Abstract] [Full Text] [Related]
5. Corrigendum to 'Salivary gland cancer: ESMO-European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up': [ESMO Open 7(6):100602, December 2022].
van Herpen C; Vander Poorten V; Skalova A; Terhaard C; Maroldi R; van Engen A; Baujat B; Locati LD; Jensen AD; Smeele L; Hardillo J; Costes Martineau V; Trama A; Kinloch E; Even C; Machiels JP;
ESMO Open; 2023 Oct; 8(5):101630. PubMed ID: 37625197
[No Abstract] [Full Text] [Related]
6. Gastrointestinal stromal tumours: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Casali PG; Jost L; Reichardt P; Schlemmer M; Blay JY;
Ann Oncol; 2009 May; 20 Suppl 4():64-7. PubMed ID: 19454466
[No Abstract] [Full Text] [Related]
7. Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Casali PG; Blay JY;
Ann Oncol; 2010 May; 21 Suppl 5():v98-102. PubMed ID: 20555113
[No Abstract] [Full Text] [Related]
8. Gastrointestinal stromal tumours (GISTs): French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO).
Landi B; Blay JY; Bonvalot S; Brasseur M; Coindre JM; Emile JF; Hautefeuille V; Honore C; Lartigau E; Mantion G; Pracht M; Le Cesne A; Ducreux M; Bouche O; ; ; ; ; ; ;
Dig Liver Dis; 2019 Sep; 51(9):1223-1231. PubMed ID: 31387778
[TBL] [Abstract][Full Text] [Related]
9. The ESMO-EURACAN-GENTURIS-ERNPaedCan Clinical Practice Guidelines for bone sarcomas - the challenges of the fight against rare cancers.
Andreou D
Ann Oncol; 2021 Dec; 32(12):1470-1471. PubMed ID: 34560241
[No Abstract] [Full Text] [Related]
10. Gastrointestinal stromal tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
ESMO / European Sarcoma Network Working Group
Ann Oncol; 2012 Oct; 23 Suppl 7():vii49-55. PubMed ID: 22997454
[No Abstract] [Full Text] [Related]
11. UK clinical practice guidelines for the management of gastrointestinal stromal tumours (GIST).
Judson I; Bulusu R; Seddon B; Dangoor A; Wong N; Mudan S
Clin Sarcoma Res; 2017; 7():6. PubMed ID: 28465823
[TBL] [Abstract][Full Text] [Related]
12. The European Society for Medical Oncology 'Magnitude of Clinical Benefit Scale' field-tested in infrequent tumour entities: an extended analysis of its feasibility at the Medical University of Vienna.
Kiesewetter B; Raderer M; Prager GW; Fuereder T; Marosi C; Preusser M; Krainer M; Locker GJ; Brodowicz T; Zielinski CC
ESMO Open; 2017; 2(3):e000166. PubMed ID: 28761758
[TBL] [Abstract][Full Text] [Related]
13. Clinical benefit of systemic treatment in patients with advanced pancreatic and gastrointestinal neuroendocrine tumours according to ESMO-MCBS and ASCO framework.
de Hosson LD; van Veenendaal LM; Schuller Y; Zandee WT; de Herder WW; Tesselaar MET; Klümpen HJ; Walenkamp AME
Ann Oncol; 2017 Dec; 28(12):3022-3027. PubMed ID: 29045525
[TBL] [Abstract][Full Text] [Related]
14. EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma.
Franceschi E; Hofer S; Brandes AA; Frappaz D; Kortmann RD; Bromberg J; Dangouloff-Ros V; Boddaert N; Hattingen E; Wiestler B; Clifford SC; Figarella-Branger D; Giangaspero F; Haberler C; Pietsch T; Pajtler KW; Pfister SM; Guzman R; Stummer W; Combs SE; Seidel C; Beier D; McCabe MG; Grotzer M; Laigle-Donadey F; Stücklin ASG; Idbaih A; Preusser M; van den Bent M; Weller M; Hau P
Lancet Oncol; 2019 Dec; 20(12):e715-e728. PubMed ID: 31797797
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Indicators for Gastrointestinal Stromal Tumors: A Review.
Zhang H; Liu Q
Transl Oncol; 2020 Oct; 13(10):100812. PubMed ID: 32619820
[TBL] [Abstract][Full Text] [Related]
16. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS.
Park K; Vansteenkiste J; Lee KH; Pentheroudakis G; Zhou C; Prabhash K; Seto T; Voon PJ; Tan DSW; Yang JCH; Wang J; Babu KG; Nakayama Y; Alip A; Chua KLM; Cheng JC; Senan S; Ahn YC; Kim TY; Ahn HK; Peters S; Yoshino T; Douillard JY
Ann Oncol; 2020 Feb; 31(2):191-201. PubMed ID: 31959336
[TBL] [Abstract][Full Text] [Related]
17. Precision guidelines for soft tissue and visceral sarcomas: the evidence, expert experience and ensuring optimal care for rare cancers, a 2021 update from ESMO-EURACAN-GENTURIS.
Gladdy RA
Ann Oncol; 2021 Nov; 32(11):1325-1326. PubMed ID: 34500045
[No Abstract] [Full Text] [Related]
18. Gastrointestinal stromal tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Casali PG; Jost L; Reichardt P; Schlemmer M; Blay JY;
Ann Oncol; 2008 May; 19 Suppl 2():ii35-8. PubMed ID: 18456761
[No Abstract] [Full Text] [Related]
19. Neuroendocrine gastroenteropancreatic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Oberg K; Akerström G; Rindi G; Jelic S;
Ann Oncol; 2010 May; 21 Suppl 5():v223-7. PubMed ID: 20555086
[No Abstract] [Full Text] [Related]
20. [Act following etiquette and change with time: analysis and discussion on the difference between the current guidelines and clinical practice of gastrointestinal stromal tumor].
Cao H; Wang M
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep; 24(9):749-757. PubMed ID: 34530554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
